Everence Capital Management Inc Exelixis, Inc. Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
A detailed history of Everence Capital Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Everence Capital Management Inc holds 8,150 shares of EXEL stock, worth $276,855. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,150Holding current value
$276,855% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
503Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$996 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$863 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$522 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$389 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...